Sander Deridder

Sander Deridder

Auto-generated profile, based on publicly available information

Sander Deridder

Vrije Universiteit Brussel, Department of Chemical Engineering, Pleinlaan 2, 1050 Brussels, Belgium

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Journal of Chromatography A
Verified
Journal Article
Closed access
SDSander Deridder
Sander Deridder
MCMartina Catani
Martina Catani
ACAlberto Cavazzini
Alberto Cavazzini
GDGert Desmet
Gert Desmet

22 July 2020 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
IRInès Van Rossem
Inès Van Rossem
JVJan Vandevoorde
Jan Vandevoorde
SHShane Hanon
Shane Hanon
SDSander Deridder
Sander Deridder
EVEef Vanderhelst
Eef Vanderhelst
Background: Blood eosinophil counts (BEC) were recently included in the 2019 Global Initiative for Obstructive Lung Disease (GOLD) guideline as an easily accessible theragnostic biomarker for Chronic Obstructive Pulmonary Disease (COPD). However, the stability of BEC remains insufficiently studied. Methods: We conducted a retrospective study in six primary care practices in Belgium on data from Electronic Health Records of stable COPD patients, to characterise the stability of blood eosinophils over time. We report the percentage of patients with BEC persistently below or above the 2019 GOLD guideline thresholds (100 and 300 cells/μL). For each patient the mean, standard deviation (SD) and relative standard deviation (RSD) of the BEC were calculated to determine the intra-patient variability. Results: Ninety-eight patients were included, yielding 1082 eosinophil measurements (median 8 measurements/patient), with BEC ranging between 0 and 1504 cells/μL. Four (4.1%) patients had BEC persistently below 100 cells/μL, 34 (34.7%) had measurements persistently above this threshold. Approximately half of the patients (51.0%) had BEC persistently below 300 cells/μL and 3 (3.1%) patients had counts persistently above this threshold. 28.6% of patients crossed both threshold values throughout the registration period. The mean BEC per patient ranged between 15 and 846 cells/μL with an intra-patient SD between 5 and 658 cells/μL. The mean intra-patient RSD was 0.46. There was a significant strong positive correlation (Pearson analyses) between the mean BEC and SD (r = 0.765; n = 98). Simple linear regression was used to further describe the influence of the mean eosinophil count on the SD (B = 0.500; 95%CI 0.415–0.586; n = 98; p < 0.001). Conclusion: BEC can be variable in individual COPD patients. Therefore, the use of a single measurement to guide therapeutic decisions remains debatable. Further prospective research remains necessary to validate the reproducibility of this biomarker.

1 June 2018 in Journal of Chromatography A
Verified
Journal Article
Closed access
SDSander Deridder
Sander Deridder
GDGert Desmet
Gert Desmet
KBKen Broeckhoven
Ken Broeckhoven

1 August 2019 in Journal of Chromatography A
Verified
Journal Article
Open access
TATheodora Adamopoulou
Theodora Adamopoulou
SNSuhas Nawada
Suhas Nawada
SDSander Deridder
Sander Deridder
BWBert Wouters
Bert Wouters
GDGert Desmet
Gert Desmet
PSPeter J. Schoenmakers
Peter J. Schoenmakers
Conventional one-dimensional column-based liquid chromatographic (LC) systems do not offer sufficient separation power for the analysis of complex mixtures. Column-based comprehensive two-dimensional liquid chromatography offers a higher separation power, yet suffers from instrumental complexity and long analysis times. Spatial two-dimensional liquid chromatography can be considered as an alternative to column-based approaches. The peak capacity of the system is ideally the product of the peak capacities of the two dimensions, yet the analysis time remains relatively short due to parallel second-dimension separations. Aspects affecting the separation efficiency of this type of systems include flow distribution to homogeneously distribute the mobile phase for the second-dimension (2D) separation, flow confinement during the first-dimension (1D) separation, and band-broadening effects during analyte transfer from the 1D separation channel to the 2D separation area. In this study, the synergy between computational fluid dynamics (CFD) simulations and rapid prototyping was exploited to address band broadening during the 2D development and analyte transfer from 1D to 2D. Microfluidic devices for spatial two-dimensional liquid chromatography were designed, simulated, 3D-printed and tested. The effects of presence and thickness of spacers in the 2D separation area were addressed and leaving these out proved to be the most efficient solution regarding band broadening reduction. The presence of a stationary-phase material in the 1D channel had a great effect on the analyte transfer from the 1D to the 2D and the resulting band broadening. Finally, pressure limit of the fabricated devices and printability are discussed.


1 November 2018 in Journal of Chromatography A
Verified
Journal Article
Closed access
SDSander Deridder
Sander Deridder
WSWim Smits
Wim Smits
HBHamza Benkahla
Hamza Benkahla
KBKen Broeckhoven
Ken Broeckhoven
GDGert Desmet
Gert Desmet